What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Immune system
His primary areas of investigation include Immunology, Genetic enhancement, Stem cell, Transplantation and Suicide gene.
His biological study spans a wide range of topics, including Hematopoietic stem cell transplantation and Graft-versus-host disease.
His research in Genetic enhancement intersects with topics in Cancer research, Metachromatic leukodystrophy and Severe combined immunodeficiency.
The study incorporates disciplines such as Progenitor cell and Hematopoietic stem cell in addition to Severe combined immunodeficiency.
His Transplantation research incorporates elements of Human leukocyte antigen and Oncology.
His Bone marrow study incorporates themes from Myeloid and T lymphocyte.
His most cited work include:
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-Leukemia (1066 citations)
- Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning (998 citations)
- Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency (814 citations)
What are the main themes of his work throughout his whole career to date?
Claudio Bordignon mainly focuses on Immunology, Internal medicine, Transplantation, NGR-hTNF and Hematopoietic stem cell transplantation.
His work deals with themes such as Genetic enhancement, Suicide gene and Stem cell, which intersect with Immunology.
Claudio Bordignon has researched Genetic enhancement in several fields, including Progenitor cell, Metachromatic leukodystrophy, Severe combined immunodeficiency and Virology.
His work focuses on many connections between Suicide gene and other disciplines, such as T cell, that overlap with his field of interest in Antigen.
The Internal medicine study combines topics in areas such as Gastroenterology, Surgery and Oncology.
His research integrates issues of Human leukocyte antigen, Bone marrow and Graft-versus-host disease in his study of Hematopoietic stem cell transplantation.
He most often published in these fields:
- Immunology (55.04%)
- Internal medicine (27.65%)
- Transplantation (22.22%)
What were the highlights of his more recent work (between 2013-2020)?
- Immunology (55.04%)
- Internal medicine (27.65%)
- Cancer research (21.19%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Immunology, Internal medicine, Cancer research, Hematopoietic stem cell transplantation and Oncology.
His research links Cytotoxic T cell with Immunology.
His Internal medicine research includes elements of Surgery and Pleural mesothelioma.
The various areas that he examines in his Cancer research study include Tumor necrosis factor alpha, Vascular-targeting agent, In vivo and Carcinogenesis.
His Hematopoietic stem cell transplantation study combines topics from a wide range of disciplines, such as Human leukocyte antigen and Graft-versus-host disease.
Claudio Bordignon combines subjects such as Haematopoiesis, CD3 and Suicide gene with his study of T cell.
Between 2013 and 2020, his most popular works were:
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells (454 citations)
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells (454 citations)
- In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells. (96 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Immune system
Claudio Bordignon focuses on Immunology, Cancer research, Immune system, Bone marrow and Hematopoietic stem cell transplantation.
The concepts of his Immunology study are interwoven with issues in Stem cell, Cell therapy and Transplantation.
His studies examine the connections between Stem cell and genetics, as well as such issues in Severe combined immunodeficiency, with regards to Haematopoiesis.
His research in Bone marrow intersects with topics in Treosulfan, Fludarabine and Graft-versus-host disease.
Hematopoietic stem cell transplantation is closely attributed to Oncology in his research.
His Donor Lymphocytes research incorporates elements of Genetic enhancement and Suicide gene.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
